PharmaCyte Biotech, Inc. Common Stock

$0.7311
-0.0289 (-3.80%)

Market Capitalization:

$7.85M

PharmaCyte Biotech Price Chart

PharmaCyte Biotech Price Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM0.77000.76340.75680.75010.74350.73690.73

PharmaCyte Biotech Volume Chart

PharmaCyte Biotech Volume Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM3.00K2.57K2.14K1.71K1.29K857429

PharmaCyte Biotech Market Segments

Premarket

*No Trades in Segment

After Hours Yesterday

+0.0008(+0.11%)
Open$0.7303
Close$0.7311
Low$0.7303
Low Change0.0000 (0.00%)
High$0.7311
High Change+0.0008 (+0.11%)
Range$0.0008
Volume1.084K
Dollar Volume$792.51

Regular Trading Hours Yesterday

+0.0100(+1.33%)
Open$0.7500
Close$0.7600
Low$0.7235
Low Change-0.0265 (-3.53%)
High$0.7700
High Change+0.0200 (+2.67%)
Range$0.0465
Volume46.875K
Dollar Volume$35.63K

Premarket Yesterday

+0.0000(+0.00%)
Open$0.7272
Close$0.7272
Low$0.7272
Low Change0.0000 (0.00%)
High$0.7272
High Change+0.0000 (+0.00%)
Range$0.0000
Volume200
Dollar Volume$145.44

PharmaCyte Biotech Moving Averages

5 Day Moving Average (SMA5)$0.7545
10 Day Moving Average (SMA10)$0.7505
20 Day Moving Average (SMA20)$0.7190
50 Day Moving Average (SMA50)$0.7142
100 Day Moving Average (SMA100)$0.7884
200 Day Moving Average (SMA200)$0.8661

PharmaCyte Biotech Statistics

Average Volume (30 Days)157.13K
P/E Ratio (Current)-1.09
EPS (Current)-$0.70
Dividend Yield1.99%
Free Cash Flow
Cash Ratio12.02
Current Ratio12.33
Quick Ratio12.33
Debt to Equity0.00
Enterprise Value-$12.01M
EV to EBITDA2.23
EV to Sales
Price to Book0.21
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.13%
Return on Equity-0.20%

PharmaCyte Biotech Stock Splits

There have been 2 stock splits for PharmaCyte Biotech (PMCB). The last reverse stock split occured on July 12, 2021 and reduced the outstanding shares at a ratio of 1500:1.

DateTypeRatio
Jul 12, 2021Reverse1500:1
Dec 8, 2003Forward1:3

PharmaCyte Biotech Dividends

There have been no dividends for PharmaCyte Biotech (PMCB).